Close Menu

Ebola

NEW YORK (GenomeWeb) — Luminex said today that the US Army Medical Research Institute of Infectious Diseases (USAMRIID) is using Luminex's xMAP technology to develop rapid diagnostics for the Ebola virus.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals this week said that it is currently amending the protocol of a Phase I trial of its RNAi-based Ebola infection therapy TKM-Ebola after US regulators halted the study amid safety concerns.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals said this week that it has been notified that the US Food and Drug Administration has placed a hold on a Phase I study of the company's siRNA-based Ebola virus drug, TKM-Ebola.

NEW YORK (GenomeWeb) – Tekmira Pharmaceuticals this week announced that it has completed the single ascending dose portion of a Phase I trial of its RNAi-based Ebola treatment TKM-Ebola, with treatment proving to be well tolerated up to .3 mg/kg.

The National Institutes of Health this month awarded roughly $1.4 million in grant money to researchers at the University of Texas and Tekmira Pharmaceuticals to support their development of a single RNAi-based drug that can treat both Ebola virus and Marburg virus infections.

Tekmira Pharmaceuticals this week announced that it has received a fast track designation for its phase I Ebola virus drug TKM-Ebola from the US Food and Drug Administration.

Tekmira Pharmaceuticals this week announced that it has dosed the first patients in a phase I trial of its next-generation Ebola virus drug TKM-Ebola.

Tekmira Pharmaceuticals said this week that it has received clearance from the US Food and Drug Administration to begin phase I testing of an improved formulation of its RNAi-based Ebola virus drug TKM-Ebola.

Genomics tools provider Lucigen has developed an isothermal amplification polymerase ideally suited for use in loop-mediated isothermal amplification-based assays.

Tekmira Pharmaceuticals this week unveiled new preclinical data from its Ebola and Marburg virus programs, showing that its siRNA-based therapies were effective in non-human primates even when treatment was delayed by as much as 48 hours after infection.

Pages

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.